Updated Results of the Prima Study Confirms the Benefit of 2-Years Rituximab Maintenance In Follicular Lymphoma Patients Responding to Immunochemotherapy.

AuthID
P-003-0YG
28
Author(s)
Salles, GA
·
Catalano, J
·
Offner, FC
·
Caballero, D
·
Brice, P
·
Pedersen, LM
·
[+2]·
[+3]·
[+1]·
[+2]·
Sebban, C
·
Lister, A
·
Estell, JA
·
Milone, G
·
Sonet, A
·
Lopez Guillermo, A
·
Seymour, JF
·
Xerri, L
Document Type
Abstract
Year published
2010
Published
in BLOOD, ISSN: 0006-4971
Volume: 116, Issue: 21, Pages: 746-746 (1)
Conference
52Nd Annual Meeting of the American-Society-Of-Hematology (Ash), Date: DEC 04-07, 2010, Location: Orlando, FL, Sponsors: Amer Soc Hematol
Indexing
Publication Identifiers
Wos: WOS:000289662202012
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.